Quick Takeaways
- This page summarizes Jane Wright-Mitchell's Form 4 filing for Vaxcyte, Inc. (PCVX).
- 3 reported transactions and 1 derivative row are listed below.
- Filing timestamp: 18 Aug 2021, 18:02.
Jane Wright-Mitchell - 16 Aug 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)
- Role
- General Counsel
- Signature
- /s/ Ron A. Metzger, Attorney-in-Fact
- Issuer symbol
- PCVX
- Transactions as of
- 16 Aug 2021
- Net transactions value
- -$59,925
- Form type
- 4
- Filing time
- 18 Aug 2021, 18:02:03 UTC
- Previous filing
- 16 Aug 2021
- Next filing
- 25 Mar 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Jane Wright-Mitchell filed Form 4 for Vaxcyte, Inc. (PCVX) on 18 Aug 2021."
What Changed
- Previous filing in this sequence was filed on 16 Aug 2021.
- Current net transaction value: -$59,925.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Common Stock | Options Exercise | $5,075 | +2,500 | +80% | $2.03* | 5,625 | 16 Aug 2021 | Direct | |
| transaction | PCVX | Common Stock | Sale | $65,000 | -2,500 | -44% | $26.00 | 3,125 | 16 Aug 2021 | Direct | F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | PCVX | Stock Option (right to buy) | Options Exercise | $0 | -2,500 | -1.3% | $0.000000 | 187,468 | 16 Aug 2021 | Common Stock | 2,500 | $2.03 | Direct | F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
| F2 | 1/4 of the shares subject to the option vested on January 7, 2020, and 1/48 of the shares vest monthly thereafter. |